Cargando…

Malignancy Risk in RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Real-World Clinical Experience

Introduction: Fine needle biopsy (FNB) is the standard procedure for thyroid nodules meeting criteria for biopsy according to current national guidelines (ATA and ACR). However, 15-25% of biopsies are categorized as indeterminate in the Bethesda Categories III (Atypical/FLUS) or IV (Follicular/Hurth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Joseph, Lupo, Mark Armin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090245/ http://dx.doi.org/10.1210/jendso/bvab048.1766

Ejemplares similares

Indeterminate Thyroid Nodules With RAS Mutations Have Higher Rates of Malignancy When Multiple Non-Cystic Nodules or Irregular Borders Are Present
por: Bernuy, Mario Carlos C Rivera, et al.
Publicado: (2021)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019)

MON-LB75 Stratifying the Risk of Malignancy in Indeterminate Thyroid Nodules
por: Imam, Shahnawaz, et al.
Publicado: (2020)

Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules
por: Offi, Chiara, et al.
Publicado: (2021)

OR27-3 A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

PSAT379 Performance of a Raman Fingerprint in Thyroid Nodules with Indeterminate Cytology: A Prospective Blinded Monocentric Study
por: Palermo, Andrea, et al.
Publicado: (2022)

MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020)

MON-569 Performance of American Thyroid Association Sonographic Risk and Gene Expression Classifier in the Diagnosis of Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytology
por: Arosemena, Marilyn, et al.
Publicado: (2019)

MON-LB79 Do Ultrasound Patterns and Clinical Parameters Modify the Probability of Thyroid Cancer Predicted by Molecular Testing in Thyroid Nodules With Indeterminate Cytology?
por: Figge, James J, et al.
Publicado: (2020)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

ODP465 BRAF V600 and NRAS Q61 mutations in thyroid fine-needle aspiration (FNA) with indeterminate cytology in Argentina
por: Repetto, Esteban M, et al.
Publicado: (2022)

OR28-05 Approaching Indeterminate Thyroid Nodules in the Absence of Molecular Markers. “The BETH-TR Score”
por: Kannan, Subramanian, et al.
Publicado: (2020)

THU680 Cytologic And Molecular Assessment Of Isthmus Thyroid Nodules
por: Jasim, Sina, et al.
Publicado: (2023)

OR32-01 Clinical Performance Of Multiplatform Molecular Diagnostic Testing Of Cytology Indeterminate Thyroid Nodules: A Blinded, Single Institution Observational Study With Surgical Pathology And Surveillance Follow Up
por: Cipriani, Nicole A, et al.
Publicado: (2023)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

PSAT267 Performance of ThyroSeq V3 molecular testing in assessing indeterminate thyroid nodules for thyroid cancer at an urban endocrinology clinic.
por: Bao, Ginny, et al.
Publicado: (2022)

Ultrasonographic Indeterminate Lymph Nodes in Preoperative Thyroid Cancer Patients: Malignancy Risk and Ultrasonographic Findings Predictive of Malignancy
por: Yoo, Roh-Eul, et al.
Publicado: (2020)

A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials
por: Zafereo, Mark, et al.
Publicado: (2020)

A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules
por: Finkelstein, Sydney D., et al.
Publicado: (2022)

MON-568 Differences in Ultrasound Characteristics, Molecular Analysis, and Management of Indeterminate Thyroid Nodules (ITN) in Older vs. Younger Patients
por: Waisayanand, Nipawan, et al.
Publicado: (2019)

SAT-LB099 Optimal Timing of Follow Up for Cytologically Benign Thyroid Nodules
por: Estrada, Allison, et al.
Publicado: (2019)

Impact of Nodule Size on Malignancy Risk Differs according to the Ultrasonography Pattern of Thyroid Nodules
por: Hong, Min Ji, et al.
Publicado: (2018)

Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology
por: Skaugen, John M., et al.
Publicado: (2022)

PSAT382 Characterization of Ultrasound and Cytological Features Identifying Thyroid Nodules with Aggressive Behavior: From Histology to Clinic
por: Latrofa, Francesco, et al.
Publicado: (2022)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

(18)F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study
por: Ciappuccini, Renaud, et al.
Publicado: (2021)

ODP493 Malignant Struma Ovarii with Papillary Thyroid Carcinoma and concomitant High Risk Thyroid Nodule
por: Chaidarun, Tanyawan, et al.
Publicado: (2022)

A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study
por: González, Hernán E., et al.
Publicado: (2017)

MON-LB095 Thyroid Nodule Localization as a Predictor Factor for Malignancy
por: Sibai, Zakaria, et al.
Publicado: (2019)

MON-LB78 Thyroid Nodules > 4cm: High-Risk for Malignancy or Not?
por: Fishel, Heather, et al.
Publicado: (2020)

TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients
por: Alaraifi, Abdulaziz K., et al.
Publicado: (2023)

SAT491 Development of Thyroidal Nodule in Congenital Hypothyroid Girl With Thyroid Peroxidase Gene Mutation
por: Lee, Jisu, et al.
Publicado: (2023)

American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules
por: Wu, Hongxun, et al.
Publicado: (2019)

SAT-570 GRIM-19 Expression May Help Diagnose Malignancy in Thyroid Nodules
por: Bufalo, Natassia, et al.
Publicado: (2019)

Malignancy Risk Stratification of Thyroid Nodules with Macrocalcification and Rim Calcification Based on Ultrasound Patterns
por: Shin, Hwa Seon, et al.
Publicado: (2021)

LBSAT244 Prospective, Blinded, Multicenter Head-to-head Clinical Comparison Of Two "TSI" Assays In Patients With Autoimmune Thyroid Disease
por: Lupo, Mark Armin, et al.
Publicado: (2022)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

Toxic Thyroid Nodule: To FNA or Not?
por: Kasina, Siva Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0amuasakk9e8bgss2keo8nc94o